Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Bastide Le Confort Médical is a publicly listed French company specializing in the sale and rental of medical equipment and home healthcare services. Founded in 1976, it operates across seven countries including France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy, with over 3,600 employees, 164 agencies, franchises, and 13 centers. The company functions through six key segments: Respiratory Assistance, Home Care, Healthcare Facilities, Nutrition/Infusion/Diabetes, Stoma Therapy/Urology/Wound Care, and E-commerce. Its product range encompasses reclining chairs, lift chairs, mobility aids like walkers, rollators, electric scooters, wheelchairs, and incontinence products such as diapers, pads, and protective garments. Bastide Le Confort Médical emphasizes human-centered values, innovation in medical technology, and partnerships with laboratories and healthcare professionals to enhance patient autonomy and well-being. In the financial markets, it represents a player in the medical equipment and services sector, focusing on supporting vulnerable populations through comprehensive home care solutions.
Operating margin is thin at 9.20%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 6.3%, steady but not accelerating.
Net debt of €386M represents 9.2x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
€491M
▲ +6.3% YoY
Net Income (TTM)
€2M
▲ +29.4% YoY
Op. Margin
9.20%
▲ +0.9pp YoY
ROIC
4.65%
▲ +0.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€42M
▲ +70.7% YoY
Op. Cash Flow (TTM)
€100M
▲ +257.5% YoY
Net Debt
€386M
Cash & Equiv.
€25M
3Y CAGR: +1.6%
3Y CAGR: +126.6%
Continue Research